Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
activist, advice, aforementioned, agenda, Almirall, AMT, Angelo, Aqua, Argosy, avoid, baby, blockage, blogging, Bulletin, buy, buying, bylaw, Canaan, Capitol, Cielo, circumstance, Codification, companywide, concert, conferred, Contempla, correctly, counterion, CSMC, CT, cybersecurity, declaratory, deprioritized, disagreement, disclaimer, DTA, DTL, East, eighteen, Endo, equated, EsomepraCareDR, excellent, exert, explanatory, FDIC, Floor, fractional, Gordon, Greg, GtN, hand, hereto, illiquidity, infraction, insight, IP, Iroko, Jain, Jefferson, Kentucky, lesser, lookback, mainstream, manipulative, Medomie, mentioned, metric, mimic, miscalculated, momentum, Nantahala, nascency, notional, occasion, omission, online, Palestinian, partnership, PFAB, plaintiff, problematic, proportionately, Pyszczymuka, quantifying, quotient, recission, reconciling, referenced, refinance, regrowth, reorienting, repeated, reply, reprioritization, reprioritized, rescind, retaliated, Riverside, running, Sabby, save, shortly, specialist, speculation, St, Stein, sublease, subleased, subleasing, sublessee, supervisor, Thornton, TIAA, Tranche, unutilized, unwelcome, urgent, veracity, videotaping, voice, VWAP, waged, Wall, Walleye, Walstib, Western, Zevra, Zogenix
Removed:
abroad, Accentia, actively, administering, advancing, advisor, allocation, AMEX, annum, area, assumption, ASX, Averaden, bacteria, bacterial, biliary, black, bladder, blend, botanical, box, broader, cancelled, capturing, Catevo, CEO, clinically, codeine, cold, communicate, compelling, confirm, consumed, continual, critically, demonstrating, denial, die, diminish, disability, disadvantage, disagree, discretionary, disposition, diversified, economy, embodying, emerging, Englewood, enroll, enrolling, enrollment, eradicating, evolve, exchanged, expend, filled, flexible, graduate, halt, highlighted, hospitalized, ILE, ill, importantly, inferior, informed, intensive, interfere, intermittent, interrupt, intubated, Isolagen, Johnson, Justice, lattice, leader, lengthy, Los, MAA, mandated, MAST, Mayne, mechanically, merged, methodology, Mitigation, multiplied, MYX, neuropathy, neurovascular, nose, novo, nutritional, outbreak, outweigh, pain, pandemic, Parkway, path, paydown, payout, peripheral, PMA, pneumonia, practical, predicted, predictive, premarket, principle, Printing, proforma, progressively, promotional, proof, put, reallocate, recession, recruit, reexamine, resource, scheduling, scientifically, sensitivity, sexual, significance, spray, spread, Stenting, Sterling, strain, suffered, suffering, surveillance, surviving, tartrate, TEAMM, therapist, tolerability, toxic, unacceptable, unacceptably, unattractive, unaudited, undergo, undesirable, unforeseen, unsuitable, urivarx, utility, validating, validation, varying, ventilated, viral, voted, Wichita, widespread, Yasoo, zolpidem
Filing tables
Filing exhibits
- 10-K Annual report
- 10.45 EX-10.45
- 10.46 EX-10.46
- 10.47 EX-10.47
- 10.48 EX-10.48
- 10.49 EX-10.49
- 10.50 EX-10.50
- 10.51 EX-10.51
- 10.52 EX-10.52
- 10.53 EX-10.53
- 10.54 EX-10.54
- 10.55 EX-10.55
- 21.1 EX-21.1
- 23.1 EX-23.1
- 23.2 EX-23.2
- 31.1 EX-31.1
- 31.2 EX-31.2
- 32.1 EX-32.1
- Download Excel data file
- View Excel data file
Related press release
Associated AYTU transcripts
AYTU similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in Aytu BioPharma, Inc. Registration Statements on Form S-8 (No. 333-255325, 333-205462, 333-236598 and 333-272897), Form S-3 (Nos. 333-259862, 333-235548, 333-236599, 333-239010 and 333-265479) and Form S-1 (File Nos. , 333-212100, 333-213489, 333-222994, 333-223385, 333-227243, 333-227706 and 333-271556) of our report dated September 27, 2022, except for Note 2, as to which the date is October 12, 2023, relating to the consolidated financial statements as of and for the year ended June 30, 2022 that appear in this Annual Report on Form 10-K.
/s/Plante & Moran, PLLC
Denver, Colorado
October 12, 2023